EndoChoice’s Fuse System Cuts Down on Missed Colon Adenomas, Study Shows

EndoChoice released research backing the FDA-approved Fuse system as a more accurate method for preventing colorectal cancer and reducing the number of adenomas missed by colonoscopists.

Advertisement

EndoChoice revealed its study at the Digestive Disease Week meeting this past May.

The Fuse system uses three small cameras at the tip of a flexible endoscope. The three cameras are designed to give physicians twice as much visibility as a traditional endoscope.

A trial of 185 patients found 42 percent of adenomas were missed by traditional colonscopes and just 8 percent were missed by the Fuse.

More Articles on Gastroenterology:
Gary La Pelusa Association Names Dr. Anaaka Prakash ‘Man of the Year’
Vice & Associates Clinical Research Expands Gastroenterology Suite, Team Members
Drs. Rayees Nizam, Thomas Lee Join Associated Gastroenterologists of Central New York

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.